Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice
- PMID: 23643669
- PMCID: PMC4120746
- DOI: 10.1016/j.ajog.2013.04.027
Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice
Conflict of interest statement
The authors report no conflict of interest.
Figures
References
-
- Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003;348:2379–85. - PubMed
-
- Tita AT, Rouse DJ. Progesterone for preterm birth prevention: an evolving intervention. Am J Obstet Gynecol. 2009;200:219–24. - PubMed
-
- Sotiriadis A, Papatheodorou S, Makrydimas G. Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis. Ultrasound Obstet Gynecol. 2012;40:257–66. - PubMed
-
- Schmouder VM, Prescott GM, Franco A, Fan-Havard P. The rebirth of progesterone in the prevention of preterm labor. Ann Pharmacothe. 2013;47:527–36. - PubMed
-
- American College of Obstetricians and Gynecologists. ACOG committee opinion no. 419: use of progesterone to reduce preterm birth. Obstet Gynecol. 2008;112:963–5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources